Episode 74: Jason Tardio, President and COO, Immunic Therapeutics

Today on the ‪@BiorasiCRO‬ Few & Far Between Podcast: Host Melissa Alesse welcomes Jason Tardio, President and COO of #ImmunicTherapeutics, to the podcast to explore the #biotech journey to R&D and commercialization. We'll also look into Immunic's novel treatments for #multiplesclerosis, true team accountability, what makes biotech and big pharma so different. Watch this episode today! #Biorasi2026 #clinicaltrials #CRO